Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Langer

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Scientific Reports|February 24, 2023
Prevalence of perioperative asymptomatic venous thromboses of the lower extremity in 30 consecutive patients undergoing transsphenoidal surgery for Cushing's diseaseTorge Huckhagel, Gülsen Atlihan, Florian Langer, et al.
Hamostaseologie|May 21, 2026
Dental Surgery without Clotting Factor Replacement Therapy during Continued Prophylaxis with Marstacimab, an Inhibitory TFPI Monoclonal AntibodyNeele K Bokemeyer, Christina C Rolling, Marcus Freytag, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 8, 2008
A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparinFrank Gerdsen, Beate Luxembourg, Florian Langer, et al.
Pathophysiology of Haemostasis and Thrombosis|November 19, 2005
Platelet activation markers in patients with venous thromboembolism without predisposing factorsFrank Gerdsen, Martin Weber, Florian Langer, et al.
British Journal of Haematology|July 9, 2002
Prolonged inhibition of von Willebrand factor-cleaving protease after splenectomy in a 22-year-old patient with acute and plasma refractory thrombotic thrombocytopenic purpuraFlorian Langer, Frauke Bergmann, Ulrich Budde, et al.
Oncology Research and Treatment|September 26, 2015
Clinical Evidence that Coagulation Activation Drives Cancer Progression--a Report of 2 CasesMinna Voigtlaender, Katharina Holstein, Sven Leuenroth, et al.
Hamostaseologie|March 2, 2023
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial CancerLennart Beckmann, Maximilian Lennartz, Annika Poch, et al.
Research and Practice in Thrombosis and Haemostasis|June 30, 2022
Thrombotic thrombocytopenia After Sinopharm BBIBP-CorV COVID-19 vaccinationRezvan Hosseinzadeh, Mohammad Barary, Hamed Mehdinezhad, et al.
Deutsches Arzteblatt International|March 6, 2019
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous ThromboembolismJan Beyer-Westendorf, Robert Klamroth, Stephan Kreher, et al.
Thrombosis Research|April 29, 2021
Myeloperoxidase has no effect on the low procoagulant activity of silica-free DNALennart Beckmann, Minna Voigtlaender, Christina C Rolling, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Scientific Reports|February 24, 2023
Prevalence of perioperative asymptomatic venous thromboses of the lower extremity in 30 consecutive patients undergoing transsphenoidal surgery for Cushing's diseaseTorge Huckhagel, Gülsen Atlihan, Florian Langer, et al.
Hamostaseologie|May 21, 2026
Dental Surgery without Clotting Factor Replacement Therapy during Continued Prophylaxis with Marstacimab, an Inhibitory TFPI Monoclonal AntibodyNeele K Bokemeyer, Christina C Rolling, Marcus Freytag, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 8, 2008
A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparinFrank Gerdsen, Beate Luxembourg, Florian Langer, et al.
Pathophysiology of Haemostasis and Thrombosis|November 19, 2005
Platelet activation markers in patients with venous thromboembolism without predisposing factorsFrank Gerdsen, Martin Weber, Florian Langer, et al.
British Journal of Haematology|July 9, 2002
Prolonged inhibition of von Willebrand factor-cleaving protease after splenectomy in a 22-year-old patient with acute and plasma refractory thrombotic thrombocytopenic purpuraFlorian Langer, Frauke Bergmann, Ulrich Budde, et al.
Oncology Research and Treatment|September 26, 2015
Clinical Evidence that Coagulation Activation Drives Cancer Progression--a Report of 2 CasesMinna Voigtlaender, Katharina Holstein, Sven Leuenroth, et al.
Hamostaseologie|March 2, 2023
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial CancerLennart Beckmann, Maximilian Lennartz, Annika Poch, et al.
Research and Practice in Thrombosis and Haemostasis|June 30, 2022
Thrombotic thrombocytopenia After Sinopharm BBIBP-CorV COVID-19 vaccinationRezvan Hosseinzadeh, Mohammad Barary, Hamed Mehdinezhad, et al.
Deutsches Arzteblatt International|March 6, 2019
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous ThromboembolismJan Beyer-Westendorf, Robert Klamroth, Stephan Kreher, et al.
Thrombosis Research|April 29, 2021
Myeloperoxidase has no effect on the low procoagulant activity of silica-free DNALennart Beckmann, Minna Voigtlaender, Christina C Rolling, et al.
Pageof 13